Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ADHD Class Warnings Could Be Strengthened Pending FDA Research

Aug 28 2006

• By The Pink Sheet

Related Content

Shire Daytrana ADHD Patch To Launch In Early July With Some Class Labeling

Apr 10 2006

ADHD Drug Cardiovascular Risk Should Be Extended to Strattera, Cmte. Says

Apr 03 2006

Shire Adderall XR Sales Suspended In Canada; FDA Stands By “Black Box”

Feb 14 2005

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window